Pdp (68071 3471 3)
Aripiprazole
Product Images NDC 68071-3471
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Aripiprazole (NDC 68071-3471). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure1 (Figure1)
Effect of other drugs on Aripiprazole:
The text provides information on the potential effects of certain drugs on Aripiprazole, a medication commonly used to treat certain mental disorders. Here are the drugs mentioned and their categorization:
1. CYP3A4 Inhibitor: ketoconazole.
2. CYP2D6 Inhibitor: quinidine.
3. CYP3A Inducer: carbamazepine.
4. Gastric Acid Blockers: famotidine.
5. Other: valproate, lithium, lorazepam.
The specific effects or interactions of these drugs with Aripiprazole are not provided in the text. It's advisable to consult a healthcare professional or refer to the medication's prescribing information for detailed information on potential drug interactions and their impact on Aripiprazole's effectiveness or safety.*
Figure2 (Figure2)
Figure3 (Figure3)
Figure4 (Figure4)
Figure5 (Figure5)
Not available*
Structure (Structure)
Figure 6 (Figure 6)
Figure 7 (Figure 7)
Figure 8 (Figure 8)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
